Papillomavirus-like particle vaccines for cervical cancer

Molecular Medicine Today

Volumn 5, Issue 5, 1999, Pages 209-215

  Schiller, John T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENITAL TRACT INFECTION; HUMAN; NONHUMAN; ONCOVIRINAE; PAPILLOMA VIRUS; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VIRUS PARTICLE;

ANIMALS; CANCER VACCINES; CLINICAL TRIALS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

EID: 0033136184     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01463-X     Document Type: Review

References (33)

1. 1 International Agency for Research on Cancer (1995) Monograph on Cancer, Human Papillomaviruses (Vol. 64), World Health Organization
2. 2 Schiller, J. and Lowy, D. (1996) Papillomavirus-like particles and HPV vaccine development, Semin. Cancer Biol. 7, 373-382
3. 3 Galloway, D.A. (1998) Is vaccination against human papillomavirus a possibility? Lancet 351, 22-24
4. 4 Volpers, C., Schirmacher, P., Streeck, R.E. and Sapp, M. (1994) Assembly of the major and minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells, Virology 200, 504-512
5. 5 Kirnbauer, R. et al. (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic, Proc. Natl. Acad. Sci. U. S. A. 89, 12180-12184
6. 6 Unckell, F., Streeck, R.E. and Sapp, M. (1997) Generation and neutralization of pseudovirions of human papillomavirus type 33, J. Virol. 71, 2934-2939
7. 7 Roden, R.B.S. et al. (1996) In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype, J. Virol. 70, 5875-5883
8. 8 White, W.I. et al (1998) In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16, J. Virol. 72, 959-964
9. 9 Milich, D.R. et al. (1997) Role of B cells in antigen presentation of the hepatitis B core, Proc. Natl. Acad. Sci. U. S. A. 94, 14648-14653
10. 10 Rose, R.C. et al. (1998) Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies, J. Virol. 72, 6151-6154
11. 11 Breitburd, F. et al. (1995) Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection, J. Virol. 69, 3959-3963
12. 12 Suzich, J.A. et al. (1995) Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas, Proc. Natl. Acad. Sci. U. S. A. 92, 11553-11557
13. 13 Kirnbauer, R. et al. (1996) Virus-like particles of Bovine Papillomavirus type 4 in prophylactic and therapeutic immunizations, Virology 219, 37-44
14. 14 Christensen, N.D. et al. (1996) Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomaviruses, J. Virol. 70, 960-965
15. 15 Lowe, R.S. et al. (1997) Human papillomavirus type 11 (HPV11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast, J. Infect. Dis. 176, 1141-1145
16. 16 Bamelli, C. et al. (1998) Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions, J. Virol. 72, 8220-8229
17. 17 Bouvet, J.P., Belec, L., Pires, R. and Pillot, J. (1994) Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination, Infect. Immun. 62, 3957-3961
18. 18 van Ginkel, F.W., VanCott, J.L., Kiyono, H. and McGhee, J.R. (1997) Mucosal immunity to human papillomavirus in the female reproductive tract, Papillomavirus Reports 8, 1-10
19. 19 Roden, R.B.S. et al. (1996) Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition, J. Virol. 70, 3298-3301
20. 20 McNeil, C. (1997) HPV vaccines for cervical cancer move toward clinic, encounter social issues, J. Natl. Cancer Inst. 89, 1664-1666
21. 21 Bosch, F.X. et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide prospective, J. Natl. Cancer Inst. 87, 796-802
22. 22 Greer, C.E. et al. (1995) Human papillomavirus (HPV) type distribution and serological response to HPV 6 virus-like particle in patients with genital warts, J. Clin. Microbiol. 33, 2058-2063
23. 23 Lorincz, A.T. (1996) Molecular methods for the detection of human papillomavirus, Obstet. Gynecol. Clin. North Am. 23, 707-730
24. 24 Schiffman, M.H. and Burk, R.D. (1997) Human papillomaviruses, in Viral Infections in Humans (Evans, A.S. and Kaslow, R., eds), pp. 983-1023, Plenum Medical Book Company
25. 25 Muller, M. et al. (1997) Chimeric papillomavirus-like particles, Virology 234, 93-111
26. 26 Greenstone, H.L. et al. (1998) Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model, Proc. Natl. Acad. Sci. U. S. A. 95, 1800-1805
27. 27 Peng, S., Frazer, I.H., Fernando, G.J. and Zhou, J. (1998) Papillomavirus-like particles can deliver defined CTL epitopes to the MHC class I pathway, Virology 240, 147-157
28. 28 Touze, A. and Coursaget, P. (1998) In vitro gene transfer using human papillomavirus-like particles, Nucleic Acids Res. 26, 1317-1323
29. 29 Donnelly, J.J. et al. (1996) Protection against papillomavirus with a polynucleotide vaccine, J. Infect. Dis. 173, 314-20
30. 30 Zhang, W. et al. (1998) Expression of human papillomavirus type 16 L1 proteins in Escherichia coli: denaturation, renaturation and self-assembly of virus-like particles in vitro, Virology 243, 423-431
31. 31 Nardelli-Haefliger, D. et al. (1997) Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice, Infect. Immun. 65, 3328-3336
32. 32 Mason, H.S. et al. (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice, Proc. Natl. Acad. Sci. U. S. A. 93, 5335-5340
33. 33 Booy, F.P. et al. (1998) Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 Å resolution, J. Mol. Biol. 281, 95-106